VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 52 filers reported holding VERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,686,027 | +156.0% | 1,727,646 | +199.7% | 0.00% | – |
| Q2 2023 | $9,253,611 | +292.1% | 576,549 | +89.6% | 0.00% | – |
| Q1 2023 | $2,360,181 | -76.2% | 304,147 | -40.8% | 0.00% | – |
| Q4 2022 | $9,934,136 | +86.6% | 513,392 | +105.5% | 0.00% | – |
| Q3 2022 | $5,323,000 | +76.0% | 249,783 | +12.4% | 0.00% | – |
| Q2 2022 | $3,025,000 | -23.7% | 222,255 | +31.7% | 0.00% | – |
| Q1 2022 | $3,964,000 | +20.3% | 168,757 | +36.9% | 0.00% | – |
| Q4 2021 | $3,294,000 | +152.2% | 123,273 | +63.8% | 0.00% | – |
| Q3 2021 | $1,306,000 | – | 75,255 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $40,289,000 | 12.90% |
| Kynam Capital Management, LP | 1,522,712 | $20,724,000 | 5.29% |
| Sofinnova Investments, Inc. | 3,181,442 | $43,299,000 | 3.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,825 | $281,057,000 | 2.93% |
| Octagon Capital Advisors LP | 575,000 | $7,826,000 | 2.09% |
| Vivo Capital, LLC | 666,666 | $9,073,000 | 0.91% |
| RA Capital Management | 1,578,820 | $21,488,000 | 0.57% |
| Alphabet Inc. | 301,580 | $4,105,000 | 0.22% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $219,000 | 0.11% |
| Polar Asset Management Partners Inc. | 294,300 | $4,005,000 | 0.05% |